Search for: "Pfizer Inc." Results 21 - 40 of 1,509
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2009, 9:55 am
(Bloomberg) -- Pfizer Inc. board member James Kilts sold 86 percent of his Pfizer shares about the same time the company began talks to buy Wyeth, according to a regulatory filing that says the transaction occurred without his knowledge.Kilts, 61, the former chief executive officer of Gillette Co., sold 13,905 Pfizer shares for $259,772 from June 3 to June 6, according to a U.S. [read post]
22 May 2007, 9:52 pm
By Donald Zuhn -- On Monday, the Federal Circuit denied a combined petition for panel rehearing and rehearing en banc filed by Plaintiff-Appellee Pfizer, Inc. [read post]
20 Mar 2008, 5:27 pm
The Court of Appeals for the Federal Circuit upheld a lower court ruling that Teva Pharmaceutical Industries Ltd. infringed two patents held by Pfizer Inc. for Celebrex, a non-steroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis. [read post]
19 Nov 2007, 3:07 pm
Singer -- In a November 16, 2007 press release, Pfizer Inc. announced that it will acquire Coley Pharmaceutical Group, Inc. [read post]
13 Nov 2014, 7:09 am by Pete Strom
Pfizer Claims Zoloft Plaintiffs in MDL Cannot Prove Causation On Wednesday, November 5th, Pfizer Inc requested that a federal judge in Pennsylvania to dismiss more than 500 cases from the Zoloft injury multidistrict litigation (MDL) because, according to the pharmaceutical giant, the plaintiffs cannot prove that the antidepressant led to birth defects. [read post]
7 Aug 2012, 10:11 am by Mike Scarcella
A subsidiary of Pfizer Inc. that paid out millions of dollars in bribes for nearly a decade has agreed to a $15 million settlement with the U.S. [read post]
6 Jun 2017, 9:04 pm by Patent Docs
By Andrew Williams -- On May 25, 2017, the FDA's Oncologic Drug Advisory Committee recommended approval of biologics license application ("BLA") 125545 submitted by Hospira Inc., a Pfizer company, for Retacrit, a proposed biosimilar to Amgen Inc.'s Epogen/Procrit (epoetin alfa). [read post]
17 Oct 2008, 1:59 pm
In a long expected move, Pfizer Inc agreed in principle yesterday to pay $894 million to settle litigation related to it's painkillers Celebrex and Bextra. [read post]
25 Jan 2009, 2:36 pm
A Pfizer-Wyeth agreement would exceed Roche Holding AG's $43.7 billion offer for the remainder of Genentech Inc., announced in July. [read post]
27 Sep 2010, 3:07 pm by Kenneth Reich
In a pending Celebrex patent action worth potentially a billion dollars brought by Brigham Young University against Pfizer Inc., BYU recently scored a few points by convincing Magistrate Judge Brooke Wells that Pfizer’s counsel should be disqualified. [read post]